Inhibition of neuronal dopamine uptake by some antiallergic drugs
- PMID: 9696404
- DOI: 10.1016/s0014-2999(98)00253-2
Inhibition of neuronal dopamine uptake by some antiallergic drugs
Abstract
The effects of 10 antiallergic drugs (astemizole, azelastine, ebastine, emedastine, epinastine, ketotifen, oxatomide, terfenadine, pemirolast and tranilast) on neuronal dopamine uptake were examined. Some drugs examined showed a concentration-dependent inhibition of [3H]dopamine uptake into synaptosomal preparations of the rat striatum. The inhibition constant (Ki) values were 231-876 nM for ebastine, terfenadine, oxatomide and astemizole. The specific binding of [3H] (1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine) (GBR12935) to the rat striatal membranes was also inhibited by these antiallergic drugs. There was a good correlation between the degrees of inhibition of [3H]dopamine uptake and [3H]GBR12935 binding. Then, the behavioral excitement induced by L-DOPA (100 mg/kg, s.c.) plus pargyline hydrochloride (80 mg/kg, i.p.) in mice was significantly enhanced by i.p. treatment with ebastine (10 mg/kg) and astemizole (5 mg/kg). These results suggest that the neuronal dopamine uptake is inhibited by some antiallergic drugs, especially ebastine.
Similar articles
-
Potentiation of L-dopa-induced behavioral excitement by histamine H1-receptor antagonists in mice.Jpn J Pharmacol. 1996 May;71(1):81-4. doi: 10.1254/jjp.71.81. Jpn J Pharmacol. 1996. PMID: 8791174
-
Effects of histamine H1 receptor antagonists on compound 48/80-induced scratching behavior in mice.Eur J Pharmacol. 1998 Jun 12;351(1):1-5. doi: 10.1016/s0014-2999(98)00288-x. Eur J Pharmacol. 1998. PMID: 9698198
-
Evidence for the sequential formation of two complexes between an uptake inhibitor, GBR 12783 [1-[2-(diphenylmethoxy)ethyl]-4-(3-phenyl-2-propenyl)piperazine], and the neuronal transporter of dopamine.J Neurochem. 1999 Jan;72(1):396-404. doi: 10.1046/j.1471-4159.1999.0720396.x. J Neurochem. 1999. PMID: 9886093
-
Preclinical comparison of ebastine and other second generation H1-antihistamines.Pharmacol Toxicol. 2001 Oct;89(4):171-6. doi: 10.1111/j.0901-9928.2001.890405.x. Pharmacol Toxicol. 2001. PMID: 11881966
-
Bioprecursor approach to drug targeting.Biochem Soc Trans. 1990 Oct;18(5):745-6. doi: 10.1042/bst0180745. Biochem Soc Trans. 1990. PMID: 1982096 Review. No abstract available.
Cited by
-
Effects of second generation of histamine H1 antagonists, cetirizine and ebastine, on the antitussive and rewarding effects of dihydrocodeine in mice.Psychopharmacology (Berl). 2003 Mar;166(2):176-80. doi: 10.1007/s00213-002-1359-9. Epub 2003 Jan 21. Psychopharmacology (Berl). 2003. PMID: 12536265
-
Effects of L-histidine depletion and L-tyrosine/L-phenylalanine depletion on sensory and motor processes in healthy volunteers.Br J Pharmacol. 2009 May;157(1):92-103. doi: 10.1111/j.1476-5381.2009.00203.x. Br J Pharmacol. 2009. PMID: 19413574 Free PMC article.
-
Abuse liability and stimulant properties of dextromethorphan and diphenhydramine combinations in rats.Psychopharmacology (Berl). 2004 Mar;172(3):277-82. doi: 10.1007/s00213-003-1650-4. Epub 2003 Nov 21. Psychopharmacology (Berl). 2004. PMID: 14634714
-
Stimulating effects of the antihistamine fexofenadine: testing the dopamine transporter hypothesis.Psychopharmacology (Berl). 2006 Jul;187(1):95-102. doi: 10.1007/s00213-006-0406-3. Epub 2006 May 23. Psychopharmacology (Berl). 2006. PMID: 16767419 Clinical Trial.
-
Effects of the histamine H₁ receptor antagonist and benztropine analog diphenylpyraline on dopamine uptake, locomotion and reward.Eur J Pharmacol. 2012 May 15;683(1-3):161-5. doi: 10.1016/j.ejphar.2012.03.003. Epub 2012 Mar 15. Eur J Pharmacol. 2012. PMID: 22445882 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources